Your browser doesn't support javascript.
loading
Glycation of fibronectin impairs angiopoietin-1/Tie-2 signaling through uncoupling Tie-2-α5ß1 integrin crosstalk.
Chen, Tangting; Zhou, Haiyan; Yuan, Shuangshuang; Deng, Xin; Li, Yongjie; Chen, Ni; You, Jingcan; Li, Rong; Li, Tian; Zheng, Youkun; Luo, Mao; Lv, Hongbin; Wu, Jianbo; Wang, Liqun.
Afiliação
  • Chen T; Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical
  • Zhou H; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Yuan S; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Deng X; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Li Y; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Chen N; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • You J; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Li R; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Li T; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Zheng Y; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Luo M; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China.
  • Lv H; Department of Ophthalmology, the Affiliated Hospital of Southwest Medical University, Luzhou, China. Electronic address: oculistlvhongbin@swmu.edu.cn.
  • Wu J; Basic Medicine Research Innovation Center for cardiometabolic diseases,Ministry of Education, Southwest Medical University, Luzhou, China; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology, Luzhou, China. Electronic ad
  • Wang L; Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical
Cell Signal ; 112: 110916, 2023 12.
Article em En | MEDLINE | ID: mdl-37806542
ABSTRACT
The dysfunction of angiopoietin-1 (Ang-1)/Tie-2 signaling pathways has been implicated in diabetic complications. However, the underlying molecular mechanisms remain unclear. Fibronectin (FN) is thought to have an important role in regulating Ang-1/Tie-2 signaling activation. But no previous study has investigated the effects of FN glycation on Ang-1/Tie-2 signaling. In the present study, FN was glycated by methylglyoxal (MGO) to investigate whether the glycation of FN contributes to diabetes-induced Ang-1/Tie-2 signaling impairment and to understand the molecular mechanisms involved. The results demonstrated that MGO-glycated FN significantly impaired Ang-1-evoked phosphorylation of Tie-2 and Akt, Ang-1-induced endothelial cell migration and tube formation and Ang-1-mediated cell survival. The glycation of FN also inhibited the binding of α5ß1 integrin to Tie-2. Moreover, FN was remarkably modified by AGEs in aortae derived from db/db mice, indicating the glycation of FN in vivo. Ang-1-induced aortic ring vessel outgrowth and Ang-1-mediated cell survival were also both significantly inhibited in aortae from db/db mice compared to that from the wild type littermates. Moreover, FN, rather than glycated FN partly restored aortic ring angiogenesis in db/db mice, indicating that the angiogenesis defect in the db/db mice are due to FN glycation. Collectively, the results in the present study suggest that the glycation of FN impairs Ang-1/Tie-2 signaling pathway by uncoupling Tie-2-α5ß1 integrin crosstalk. This may provide a mechanism for Ang-1/Tie-2 signaling dysfunction and angiogenesis failure in diabetic ischaemic diseases.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibronectinas / Diabetes Mellitus Limite: Animals Idioma: En Revista: Cell Signal Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibronectinas / Diabetes Mellitus Limite: Animals Idioma: En Revista: Cell Signal Ano de publicação: 2023 Tipo de documento: Article